Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LASSMANN H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 159 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lassmann, H; Bruck, W; Lucchinetti, C
      Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy

      TRENDS IN MOLECULAR MEDICINE
    2. Abbruzzese, G; Agid, Y; Albanese, A; Alf, C; Allen, R; Amar, K; de Andrade, LA; Ang, LC; Angelini, C; Archer, RL; Arunodaya, GR; Baltzan, M; Baral, K; Barnett, H; Bergamasco, B; Berger, M; Bernard, J; Bharucha, NE; Bhatia, K; Blary, N; Black, S; Bodis-Wollner, I; Boyson, SJ; Bral-Kulaksizoglu, I; Brooks, DJ; Brown, JD; Burke, RE; Calne, DOC; Calne, SM; Cardoso, F; Cardozo-Pelaez, F; Chang, YJ; Chen, CC; Chen, RS; Chen, R; Chowdhury, A; Christie, S; Chu, CC; Chu, NS; Clarida, L; Collette, EM; Comella, C; Conneally, PM; Crossman, AR; Csanda, E; Dalmau, J; Dalvi, A; De Feijter, A; Deecke, L; Desai, H; De Ybenes, J; Dihenia, B; Direnfeld, L; Dodel, R; Donat, J; Doudet, D; Duane, DD; Duff, J; Duvoisin, R; Eggert, K; Elble, RJ; Elmer, LW; Emre, M; Fariello, R; Fernendy, HH; Findley, LJ; Fink, S; Freissmuth, M; Friedman, JH; de la Fuente-Fernandez, R; Furtado, S; Furukawa, Y; Galvez-Jimenez, N; Gauthier, S; Gawel, MJ; Gilman, S; Gladstone, RM; Goetz, CG; Gomori, A; Gopinathan, G; Gordin, A; Gorell, JM; Greenamyre, JT; Grimes, DA; Gurvit, H; Guttman, M; Guzman, DA; Hachinski, V; Hanagasi, H; Hardy, J; Harik, SJ; Hassan, MN; Hattori, N; Hauser, RA; Hayashi, H; Heller, GL; Hobson, D; Hochschorner, G; Hortnagel, H; Horowski, R; Howse, DC; Huang, CC; Huk, II; Hurtig, H; Hutton, JT; Jaffe, ME; Jankovic, J; Jardine, M; Jog, M; Johnson, B; Kagamihara, Y; Karagoz, N; Kasper, S; Kato, S; Kebabian, JW; Kertsz, A; Khadilkar, SV; Kirk, A; Kish, S; Kitaguchi, T; Kofman, OS; Koide, R; Komori, T; Kostyuk, PG; Kumar, R; Kuo, HC; Kurlan, R; Kurland, L; Kurtuncu, M; Lalkaka, JA; Lambert, M; Landau, W; Lang, AE; Lassmann, H; Lee, CS; Lees, AJ; Lieberman, A; Litvan, I; Loeb, C; Logan, WJ; Lozano, AM; Lu, CS; Lucy, D; Lynch, T; Manyam, BV; Maraganore, D; Marshall, FT; Martin, WRW; Martin, WE; Mathias, C; Matsubera, S; Mendis, T; Menkes, JH; Metz, LN; Miyazaki, Y; Mizuno, Y; Mohr, E; Moodley, LG; Moore, R; Morris, JL; Muthane, U; Nagaraja, D; Nair, CPV; Narabayashi, H; Nomura, Y; Norris, JW; Obeso, JA; O'Brien, C; Oertel, W; Ohtake, T; Okiyama, R; Ozdemir, C; Pal, PK; Panisset, M; Paty, DW; Paulson, GW; Perlmutter, J; Pfeiffer, RF; Pifl, C; Pincus, JH; Poewe, W; Quinn, N; Rajput, AH; Rajput, A; Ransmayr, G; Rascol, O; Robinson, R; Rocca, WA; Roos, RAC; Rosenfeld, MR; Russell, D; Ruth, TJ; Ryu, SJ; Sachdev, H; Safoschnik, G; Sahin, H; Sanchez-Ramos, J; Satishchandra, P; Schapira, A; Scheltens; Schmidley, JW; Schnaberth, G; Schneider, E; Schneider, JS; Schutz, W; Seeberger, LC; Segawa, M; Sethi, KD; Shah, A; Shannon, K; Shelton, P; Shihabuddin, B; Shimizu, T; Shinotoh, H; Siddique, T; Siderowf, A; Sieghart, W; Simard, A; Simmonds, DC; Singhal, BS; Sluga, E; Snow, BJ; Soukop, W; Sperk, G; Spieker, S; Steele, JC; Stewart, S; Stoessl, AJ; Subramony, SH; Sundaram, M; Sung, CY; Surya, N; Sweet, RD; Tabbal, SD; Takahashi, H; Taniguchi, M; Tarsy, D; Teravainen, H; Tetrud, JW; Tolosa, E; Tourtellotte, WW; Troupin, AS; Tsui, JKC; Tuite, P; Uc, EY; Ueki, Y; Uitti, R; Uyu, C; van Hilten, JJ; Veerendrakumar, M; Veloso, F; Viallet, F; Voll, C; Vrooman, M; Wang, X; Ward, I; Ward, A; Waters, C; Weng, YH; Wenning, GK; Williams, BJ; Wilson, TW; Wolters, EC; Wooten, FG; Wszolek, Z; Yahr, MD; Yanagisawa, N; Yokochi, F; Young, RR; Yu, CM; Zifko, U
      An open letter to the Committee on the Nobel Prize in Medicine

      PARKINSONISM & RELATED DISORDERS
    3. Lassmann, H
      Classification of demyelinating diseases at the interface between etiologyand pathogenesis

      CURRENT OPINION IN NEUROLOGY
    4. Flugel, A; Berkowicz, T; Ritter, T; Labeur, M; Jenne, DE; Li, ZX; Ellwart, JW; Willem, M; Lassmann, H; Wekerle, H
      Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis

      IMMUNITY
    5. Gerber, J; Bruck, W; Stadelmann, C; Bunkowski, S; Lassmann, H; Nau, R
      Expression of death-related proteins in dentate granule cells in human bacterial meningitis

      BRAIN PATHOLOGY
    6. Stadelmann, C; Mews, I; Srinivasan, A; Deckwerth, TL; Lassmann, H; Bruck, W
      Expression of cell death-associated proteins in neuronal apoptosis associated with pontosubicular neuron necrosis

      BRAIN PATHOLOGY
    7. Lassmann, H; Wekerle, H; Hickey, WF; Antel, J
      Neuroinflammation - Editorial

      GLIA
    8. Bauer, J; Rauschka, H; Lassmann, H
      Inflammation in the nervous system: The human perspective

      GLIA
    9. Bitsch, A; Kuhlmann, T; Stadelmann, C; Lassmann, H; Lucchinetti, C; Bruck, W
      A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

      ANNALS OF NEUROLOGY
    10. Gold, R; Stadelmann, C; Bruck, W; Lassmann, H
      Apoptotic cell death in neuroinflammatory and neurodegenerative diseases

      AKTUELLE NEUROLOGIE
    11. Jagodic, M; Kornek, B; Weissert, R; Lassmann, H; Olsson, T; Dahlman, I
      Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis

      IMMUNOGENETICS
    12. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, HP; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Freimuller, M; Hartung, HP; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Vass, K; Altenkirch, H; Boese, J; Gass, A; Gehlen, W; Goebels, N; Haas, J; Haferkamp, G; Heidenreich, F; Heitmann, R; Hemmer, B; Hohlfeld, R; Janzen, RWC; Jugelt, E; Kolmel, W; Konig, N; Kowitzsch, K; Manegold, U; Melms, A; Mertin, J; Petereit, HF; Pette, M; Pohlau, D; Poser, S; Sailer, M; Schmidt, S; Schock, G; Schulz, M; Seidel, D; Stangel, M; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, UK; Zipp, F; Zschenderlein, R; Bayas, A; Chan, A; Flachenecker, P; Gold, R; Grauer, O; Jung, S; Kallmann, B; Leussink, V; Maurer, M; Rieckmann, P; Toyka, KV; Weilbach, FX
      Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement

      NERVENARZT
    13. Cornet, A; Savidge, TC; Cabarrocas, J; Deng, WL; Colombel, JF; Lassmann, H; Desreumaux, P; Liblau, RS
      Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease?

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    14. Weissert, R; de Graaf, KL; Storch, MK; Barth, S; Linington, C; Lassmann, H; Olsson, T
      MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis

      JOURNAL OF IMMUNOLOGY
    15. Eugster, HP; Frei, K; Winkler, F; Koedel, U; Pfister, W; Lassmann, H; Fontana, A
      Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway

      EUROPEAN JOURNAL OF IMMUNOLOGY
    16. Flugel, A; Matsumuro, K; Neumann, H; Klinkert, WEF; Birnbacher, R; Lassmann, H; Otten, U; Wekerle, H
      Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration

      EUROPEAN JOURNAL OF IMMUNOLOGY
    17. Stefferl, A; Storch, MK; Linington, C; Stadelmann, C; Lassmann, H; Pohl, T; Holsboer, F; Tilders, FJH; Reul, JMHM
      Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone

      ENDOCRINOLOGY
    18. Kornek, B; Storch, MK; Bauer, J; Djamshidian, A; Weissert, R; Wallstroem, E; Stefferl, A; Zimprich, F; Olsson, T; Linington, C; Schmidbauer, M; Lassmann, H
      Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis

      BRAIN
    19. Trebst, C; Sorensen, TL; Kivisakk, P; Cathcart, MK; Hesselgesser, J; Horuk, R; Sellebjerg, F; Lassmann, H; Ransohoff, RM
      CCR1+/CCR5+mononuclear phagocytes accumulate in the central nervous systemof patients with multiple sclerosis

      AMERICAN JOURNAL OF PATHOLOGY
    20. Lassmann, H
      The new pathology of multiple sclerosis

      MULTIPLE SCLEROSIS
    21. Neuchrist, C; Kornfehl, J; Lassmann, H
      Migration-associated adhesion molecules in squamous cell carcinomas of thehead and neck

      ONKOLOGIE
    22. Lucchinetti, C; Bruck, W; Parisi, J; Scheithauer, B; Rodriguez, M; Lassmann, H
      Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

      ANNALS OF NEUROLOGY
    23. Stadelmann, C; Lassmann, H
      Detection of apoptosis in tissue sections

      CELL AND TISSUE RESEARCH
    24. Abdul-Majid, KB; Jirholt, J; Stadelmann, C; Stefferl, A; Kjellen, P; Wallstrom, E; Holmdahl, R; Lassmann, H; Olsson, T; Harris, RA
      Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement

      JOURNAL OF NEUROIMMUNOLOGY
    25. Hohlfeld, R; Kerschensteiner, M; Stadelmann, C; Lassmann, H; Wekerle, H
      The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    26. Stefferl, A; Schubart, A; Storch, M; Amini, A; Mather, I; Lassmann, H; Linington, C
      Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis

      JOURNAL OF IMMUNOLOGY
    27. Babbe, H; Roers, A; Waisman, A; Lassmann, H; Goebels, N; Hohlfeld, R; Friese, M; Schroder, R; Deckert, M; Schmidt, S; Ravid, R; Rajewsky, K
      Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cellpolymerase chain reaction

      JOURNAL OF EXPERIMENTAL MEDICINE
    28. Meixner, A; Haverkamp, S; Wassle, H; Fuhrer, S; Thalhammer, J; Kropf, N; Bittner, RE; Lassmann, H; Wiche, G; Propst, F
      MAP1B is required for axon guidance and is involved in the development of the central and peripheral nervous system

      JOURNAL OF CELL BIOLOGY
    29. Probert, L; Eugster, HP; Akassoglou, K; Bauer, J; Frei, K; Lassmann, H; Fontana, A
      TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease

      BRAIN
    30. Kornek, B; Storch, MK; Weissert, R; Wallstroem, E; Stefferl, A; Olsson, T; Linington, C; Schmidbauer, M; Lassmann, H
      Multiple sclerosis and chronic autoimmune encephalomyelitis - A comparative quantitative study of axonal injury in active, inactive, and remyelinatedlesions

      AMERICAN JOURNAL OF PATHOLOGY
    31. Dewey, RA; Morrissey, G; Cowsill, CM; Stone, D; Bolognani, F; Dodd, NJF; Southgate, TD; Klatzmann, D; Lassmann, H; Castro, MG; Lowenstein, PR
      Chronic brain inflammation and persistent herpes simplex virus 1 thymidinekinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

      NATURE MEDICINE
    32. Bittner, RE; Anderson, LVB; Burkhardt, E; Bashir, R; Vafiadaki, E; Ivanova, S; Raffelsberger, T; Maerk, I; Hoger, H; Jung, M; Karbasiyan, M; Storch, M; Lassmann, H; Moss, JA; Davison, K; Harrison, R; Bushby, KMD; Reis, A
      Dysterlin deletion in SJL mice (SJL-Dysf) defines a natural model for limbgirdle muscular dystrophy 2B

      NATURE GENETICS
    33. Kornek, B; Lassmann, H
      Axonal pathology in multiple sclerosis. A historical note

      BRAIN PATHOLOGY
    34. Dahlman, I; Wallstrom, E; Weissert, R; Storch, M; Kornek, B; Jacobsson, L; Linington, C; Luthman, H; Lassmann, H; Olsson, T
      Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18

      HUMAN MOLECULAR GENETICS
    35. Lassmann, H
      The pathology of multiple sclerosis and its evolution

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    36. Kuhlmann, T; Lucchinetti, C; Zettl, UK; Bitsch, A; Lassmann, H; Bruck, W
      Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions

      GLIA
    37. Lassmann, H
      Mechanisms of demyelination and tissue damage in multiple sclerosis

      ACTA NEUROLOGICA BELGICA
    38. Bitsch, A; Bruhn, H; Vougioukas, V; Stringaris, A; Lassmann, H; Frahm, J; Bruck, W
      Inflammatory CNS demyelination: Histopathologic correlation with in vivo quantitative proton MR spectroscopy

      AMERICAN JOURNAL OF NEURORADIOLOGY
    39. Muraro, PA; Martin, R; Lassmann, H; Gambi, D
      Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy

      JOURNAL OF NEUROIMMUNOLOGY
    40. Weerth, S; Berger, T; Lassmann, H; Linington, C
      Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat

      JOURNAL OF NEUROIMMUNOLOGY
    41. Schmidt, S; Hertfelder, HJ; von Spiegel, T; Hering, R; Harzheim, M; Lassmann, H; Deckert-Schluter, M; Schlegel, U
      Lethal capillary leak syndrome after a single administration of interferonbeta-1b

      NEUROLOGY
    42. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, H; Rihs, F; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Freimuller, O; Hartung, HP; Kollegger, W; Kristoferitsch, W; Vass, K; Lassmann, H; Markut, S; Altenkirch, H; Boese, J; Gehlen, W; Goebels, N; Gold, R; Haas, J; Haferkamp, G; Heidenreic, F; Heitmann, R; Hohlfeld, R; Jugelt, E; Kolmel, H; Konig, N; Lowitzsch, K; Manegold, U; Mertin, J; Pette, M; Poser, S; Sailer, J; Schack, G; Schulz, M; Seidel, D; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, U; Zipp, F; Zschenderlein, R; Rieckmann, P; Toyka, KV; Chan, A; Bayas, A; Maurer, M; Jung, S; Gold, R; Weilbach, F; Cursiefen, S; Flachenecker, P; Rieckmann, P
      Escalating immunomodulatory therapy of multiple sclerosis

      NERVENARZT
    43. Stefferl, A; Brehm, U; Storch, M; Lambracht-Washington, D; Bourquin, C; Wonigeit, K; Lassmann, H; Linington, C
      Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response

      JOURNAL OF IMMUNOLOGY
    44. Kerschensteiner, M; Gallmeier, E; Behrens, L; Leal, VV; Misgeld, T; Klinkert, WEF; Kolbeck, R; Hoppe, E; Oropeza-Wekerle, RL; Bartke, I; Stadelmann, C; Lassmann, H; Wekerle, H; Hohlfeld, R
      Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?

      JOURNAL OF EXPERIMENTAL MEDICINE
    45. Kassiotis, G; Bauer, J; Akassoglou, K; Lassmann, H; Kollias, G; Probert, L
      A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice

      EUROPEAN JOURNAL OF IMMUNOLOGY
    46. Eugster, HP; Frei, K; Bachmann, R; Bluethmann, H; Lassmann, H; Fontana, A
      Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

      EUROPEAN JOURNAL OF IMMUNOLOGY
    47. Lucchinetti, C; Bruck, W; Parisi, J; Scheithauer, B; Rodriguez, M; Lassmann, H
      A quantitative analysis of oligodendrocytes in multiple sclerosis lesions - A study of 113 cases

      BRAIN
    48. Stadelmann, C; Deckwerth, TL; Srinivasan, A; Bancher, C; Bruck, W; Jellinger, K; Lassmann, H
      Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease - Evidence for apoptotic cell death

      AMERICAN JOURNAL OF PATHOLOGY
    49. Bachmann, R; Eugster, HP; Frei, K; Fontana, A; Lassmann, H
      Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice

      AMERICAN JOURNAL OF PATHOLOGY
    50. Lassmann, H; Jellinger, KA
      In memoriam Henry M. Wisniewski, MD, Ph.D.

      ACTA NEUROPATHOLOGICA
    51. Bauer, J; Stadelmann, C; Bancher, C; Jellinger, K; Lassmann, H
      Apoptosis of T lymphocytes in acute disseminated encephalomyelitis

      ACTA NEUROPATHOLOGICA
    52. Bradl, M; Bauer, J; Inomata, T; Zielasek, J; Nave, KA; Toyka, K; Lassmann, H; Wekerle, H
      Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis

      ACTA NEUROPATHOLOGICA
    53. LASSMANN H
      NEUROPATHOLOGY IN MULTIPLE-SCLEROSIS - NEW CONCEPTS

      Multiple sclerosis
    54. LASSMANN H
      HETEROGENEITY OF MULTIPLE-SCLEROSIS IMMUNOPATHOLOGY

      European journal of neurology
    55. KASSIOTIS G; PASPARAKIS M; BAUER J; LASSMANN H; PROBERT L; KOLLIAS G
      INVESTIGATION OF TNF-TARGETS IN A TNF TRANSGENIC MODEL FOR MULTIPLE-SCLEROSIS USING A CELL-SPECIFIC GENE TARGETING APPROACH

      European cytokine network
    56. STORCH MK; STEFFERL A; BREHM U; WEISSERT R; WALLSTROM E; KERSCHENSTEINER M; OLSSON T; LININGTON C; LASSMANN H
      AUTOIMMUNITY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN IN RATS MIMICS THE SPECTRUM OF MULTIPLE-SCLEROSIS PATHOLOGY

      Brain pathology
    57. STORCH MK; PIDDLESDEN S; HALTIA M; IIVANAINEN M; MORGAN P; LASSMANN H
      MULTIPLE-SCLEROSIS - IN-SITU EVIDENCE FOR ANTIBODY AND COMPLEMENT-MEDIATED DEMYELINATION

      Annals of neurology
    58. Lucchinetti, CF; Brueck, W; Rodriguez, M; Lassmann, H
      Multiple sclerosis: Lessons from neuropathology

      SEMINARS IN NEUROLOGY
    59. LASSMANN H; RAINE CS; ANTEL J; PRINEAS JW
      IMMUNOPATHOLOGY OF MULTIPLE-SCLEROSIS - REPORT ON AN INTERNATIONAL MEETING HELD AT THE INSTITUTE OF NEUROLOGY OF THE UNIVERSITY-OF-VIENNA

      Journal of neuroimmunology
    60. LAMAN JD; VANMEURS M; SCHELLEKENS MM; DEBOER M; MELCHERS B; MASSACESI L; LASSMANN H; CLAASSEN E; THART BA
      EXPRESSION OF ACCESSORY MOLECULES AND CYTOKINES IN ACUTE EAE IN MARMOSET MONKEYS (CALLITHRIX-JACCHUS)

      Journal of neuroimmunology
    61. PERRY G; NUNOMURA A; LUCASSEN P; LASSMANN H; SMITH MA
      APOPTOSIS AND ALZHEIMERS-DISEASE

      Science
    62. BIRNBACHER R; AMANN G; BREITSCHOPF H; LASSMANN H; SUCHANEK G; HEINZERIAN P
      CELLULAR-LOCALIZATION OF INSULIN-LIKE-GROWTH-FACTOR-II MESSENGER-RNA IN THE HUMAN FETUS AND THE PLACENTA - DETECTION WITH A DIGOXIGENIN-LABELED CRNA PROBE AND IMMUNOCYTOCHEMISTRY

      Pediatric research
    63. ARCHELOS JJ; JUNG S; RINNER W; LASSMANN H; MIYASAKA M; HARTUNG HP
      ROLE OF THE LEUKOCYTE-ADHESION MOLECULE L-SELECTIN IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

      Journal of the neurological sciences
    64. LUCCHINETTI CF; BRUCK W; PARISI J; SCHEITHAUER B; RODRIGUEZ M; LASSMANN H
      PATTERNS OF MULTIPLE-SCLEROSIS IMMUNOPATHOLOGY

      Journal of neuropathology and experimental neurology
    65. STADELMANN C; BRUCK W; BANCHER C; JELLINGER K; LASSMANN H
      ALZHEIMER-DISEASE - DNA FRAGMENTATION INDICATES INCREASED NEURONAL VULNERABILITY, BUT NOT APOPTOSIS

      Journal of neuropathology and experimental neurology
    66. LUCCHINETTI CF; BRUCK W; RODRIGUEZ M; LASSMANN H
      PATTERNS OF MULTIPLE-SCLEROSIS IMMUNOPATHOLOGY

      Journal of neurochemistry
    67. LITZENBURGER T; FASSLER R; BAUER J; LASSMANN H; LININGTON C; WEKERLE H; IGLESIAS A
      B-LYMPHOCYTES PRODUCING DEMYELINATING AUTOANTIBODIES - DEVELOPMENT AND FUNCTION IN GENE-TARGETED TRANSGENIC MICE

      The Journal of experimental medicine
    68. LOBELL A; WEISSERT R; STORCH MK; SVANHOLM C; DEGRAAF KL; LASSMANN H; ANDERSSON R; OLSSON T; WIGZELL H
      VACCINATION WITH DNA ENCODING AN IMMUNODOMINANT MYELIN BASIC-PROTEIN PEPTIDE TARGETED TO FC OF IMMUNOGLOBULIN-G SUPPRESSES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

      The Journal of experimental medicine
    69. WEISSERT R; WALLSTROM E; STORCH MK; STEFFERL A; LORENTZEN J; LASSMANN H; LININGTON C; OLSSON T
      MHC HAPLOTYPE-DEPENDENT REGULATION OF MOG-INDUCED EAE IN RATS

      The Journal of clinical investigation
    70. STOCKINGER W; HENGSTSCHLAGEROTTNAD E; NOVAK S; MATUS A; HUTTINGER M; BAUER J; LASSMANN H; SCHNEIDER WJ; NIMPF J
      THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE FAMILY - DIFFERENTIAL EXPRESSION OF 2 ALPHA(2)-MACROGLOBULIN RECEPTORS IN THE BRAIN

      The Journal of biological chemistry
    71. EUGSTER HP; FREI K; KOPF M; LASSMANN H; FONTANA A
      IL-6-DEFICIENT MICE RESIST MYELIN OLIGODENDROCYTE GLYCOPROTEIN-INDUCED AUTOIMMUNE ENCEPHALOMYELITIS

      European Journal of Immunology
    72. SAHRBACHER UC; LECHNER F; EUGSTER HP; FREI K; LASSMANN H; FONTANA A
      MICE WITH AN INACTIVATION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE GENEARE SUSCEPTIBLE TO EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

      European Journal of Immunology
    73. BAUER J; BRADL M; HICKEY WF; FORSSPETTER S; BREITSCHOPF H; LININGTON C; WEKERLE H; LASSMANN H
      T-CELL APOPTOSIS IN INFLAMMATORY BRAIN-LESIONS - DESTRUCTION OF T-CELLS DOES NOT DEPEND ON ANTIGEN RECOGNITION

      The American journal of pathology
    74. AKASSOGLOU K; BAUER J; KASSIOTIS G; PASPARAKIS M; LASSMANN H; KOLLIAS G; PROBERT L
      OLIGODENDROCYTE APOPTOSIS AND PRIMARY DEMYELINATION INDUCED BY LOCAL TNF P55TNF RECEPTOR SIGNALING IN THE CENTRAL-NERVOUS-SYSTEM OF TRANSGENIC MICE - MODELS FOR MULTIPLE-SCLEROSIS WITH PRIMARY OLIGODENDROGLIOPATHY/

      The American journal of pathology
    75. THART BA; BAUER J; MULLER HJ; MELCHERS B; NICOLAY K; BROK H; BONTROP RE; LASSMANN H; MASSACESI L
      HISTOPATHOLOGICAL CHARACTERIZATION OF MAGNETIC-RESONANCE IMAGING-DETECTABLE BRAIN WHITE-MATTER LESIONS IN A PRIMATE MODEL OF MULTIPLE-SCLEROSIS - A CORRELATIVE STUDY IN THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MODEL IN COMMON MARMOSETS (CALLITHRIX-JACCHUS)

      The American journal of pathology
    76. LASSMANN H; BRUCK W; LUCCHINETTI C; RODRIGUEZ M
      REMYELINATION IN MULTIPLE-SCLEROSIS

      Multiple sclerosis
    77. STORCH M; LASSMANN H
      PATHOLOGY AND PATHOGENESIS OF DEMYELINATING DISEASES

      Current opinion in neurology
    78. STORCH MK; STEFFERJ A; WEISSERT R; WALLSTROM E; OLSSON T; LININGTON C; LASSMANN H
      MOG - A TARGET AUTOANTIGEN INDUCING MULTIPLE SCLEROSIS-LIKE LESIONS

      Brain pathology
    79. KOJIMA K; REINDL M; LASSMANN H; WEKERLE H; LININGTON C
      THE THYMUS AND SELF-TOLERANCE - COEXISTENCE OF ENCEPHALITOGENIC S100-BETA-SPECIFIC T-CELLS AND THEIR NOMINAL AUTOANTIGEN IN THE NORMAL ADULT-RAT THYMUS

      International immunology
    80. LASSMANN H; BARTSCH U; MONTAG D; SCHACHNER M
      DYING-BACK OLIGODENDROGLIOPATHY - A LATE SEQUEL OF MYELIN-ASSOCIATED GLYCOPROTEIN DEFICIENCY

      Glia
    81. BARACLATAS V; SUCHANEK G; BREITSCHOPF H; STUEHLER A; WEGE H; LASSMANN H
      PATTERNS OF OLIGODENDROCYTE PATHOLOGY IN CORONAVIRUS-INDUCED SUBACUTEDEMYELINATING ENCEPHALOMYELITIS IN THE LEWIS RAT

      Glia
    82. ANDRA K; LASSMANN H; BITTNER R; SHORNY S; FASSLER R; PROPST F; WICHE G
      TARGETED INACTIVATION OF PLECTIN REVEALS ESSENTIAL FUNCTION IN MAINTAINING THE INTEGRITY OF SKIN, MUSCLE, AND HEART CYTOARCHITECTURE

      Genes & development
    83. BRUCK W; BITSCH A; KOLENDA H; BRUCK Y; STIEFEL M; LASSMANN H
      INFLAMMATORY CENTRAL-NERVOUS-SYSTEM DEMYELINATION - CORRELATION OF MAGNETIC-RESONANCE-IMAGING FINDINGS WITH LESION PATHOLOGY

      Annals of neurology
    84. FORSSPETTER S; WERNER H; BERGER J; LASSMANN H; MOLZER B; SCHWAB MH; BERNHEIMER H; ZIMMERMANN F; NAVE KA
      TARGETED INACTIVATION OF THE X-LINKED ADRENOLEUKODYSTROPHY GENE IN MICE

      Journal of neuroscience research
    85. POULY S; STORCH MK; MATTHIEU JM; LASSMANN H; MONNETTSCHUDI F; HONEGGER P
      DEMYELINATION INDUCED BY PROTEIN-KINASE C-ACTIVATING TUMOR PROMOTERS IN AGGREGATING BRAIN-CELL CULTURES

      Journal of neuroscience research
    86. RINNER WA; PIFL C; LASSMANN H; HORTNAGL H
      INDUCTION OF APOPTOSIS IN-VITRO AND IN-VIVO BY THE CHOLINERGIC NEUROTOXIN ETHYLCHOLINE AZIRIDINIUM

      Neuroscience
    87. BANCHER C; LASSMANN H; BREITSCHOPF H; JELLINGER KA
      MECHANISMS OF CELL-DEATH IN ALZHEIMERS-DISEASE

      Journal of neural transmission. Supplementum
    88. LASSMANN H
      BASIC MECHANISMS OF BRAIN INFLAMMATION

      Journal of neural transmission. Supplementum
    89. KOJIMA K; WEKERLE H; LASSMANN H; BERGER T; LININGTON C
      INDUCTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY CD4(-CELLS SPECIFIC FOR AN ASTROCYTE PROTEIN, S100-BETA() T)

      Journal of neural transmission. Supplementum
    90. GOLD R; HARTUNG HP; LASSMANN H
      T-CELL APOPTOSIS IN AUTOIMMUNE-DISEASES - TERMINATION OF INFLAMMATIONIN THE NERVOUS-SYSTEM AND OTHER SITES WITH SPECIALIZED IMMUNE-DEFENSEMECHANISMS

      Trends in neurosciences
    91. BAJRAMOVIC JJ; LASSMANN H; VANNOORT JM
      EXPRESSION OF ALPHA-B-CRYSTALLIN IN GLIA CELLS DURING LESIONAL DEVELOPMENT IN MULTIPLE-SCLEROSIS

      Journal of neuroimmunology
    92. KLINKERT WEF; KOJIMA K; LESSLAUER W; RINNER W; LASSMANN H; WEKERLE H
      TNF-ALPHA RECEPTOR FUSION PROTEIN PREVENTS EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND DEMYELINATION IN LEWIS RATS - AN OVERVIEW

      Journal of neuroimmunology
    93. NASEL C; ROSSLER K; HEIMBERGER K; GORZER H; LASSMANN H; SCHINDLER E
      TUMOR BLOOD-FLOW AND PARTITION-COEFFICIENTS - CORRELATION WITH GRADE OF CEREBRAL GLIOMAS USING XENON-ENHANCED COMPUTED-TOMOGRAPHY

      Neuroradiology
    94. BERGER T; WEERTH S; KOJIMA K; LININGTON C; WEKERLE H; LASSMANN H
      EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS - THE ANTIGEN-SPECIFICITY OF T-LYMPHOCYTES DETERMINES THE TOPOGRAPHY OF LESIONS IN THE CENTRAL AND PERIPHERAL NERVOUS-SYSTEM

      Laboratory investigation
    95. BREHM U; STEFFERL A; STORCH M; LASSMANN H; LININGTON C
      AUTOANTIBODY RESPONSES TO THE MYELIN OLIGODENDROCYTE GLYCOPROTEIN SPECIFIC (MOG) INITIATE CLINICAL-DISEASE AND TISSUE DESTRUCTION IN THE EAE-RESISTANT BN RAT

      Journal of neurochemistry
    96. STUHLER A; FLORY E; WEGE H; LASSMANN H; WEGE H
      NO EVIDENCE FOR QUASI-SPECIES POPULATIONS DURING PERSISTENCE OF THE CORONAVIRUS MOUSE HEPATITIS-VIRUS JHM - SEQUENCE CONSERVATION WITHIN THE SURFACE GLYCOPROTEIN GENE-S IN LEWIS RATS

      Journal of General Virology
    97. MALIPIERO U; FREI K; SPANAUS KS; AGRESTI C; LASSMANN H; HAHNE M; TSCHOPP J; EUGSTER HP; FONTANA A
      MYELIN OLIGODENDROCYTE GLYCOPROTEIN-INDUCED AUTOIMMUNE ENCEPHALOMYELITIS IS CHRONIC RELAPSING IN PERFORIN KNOCKOUT MICE, BUT MONOPHASIC IN FAS-DEFICIENT AND FAS LIGAND-DEFICIENT LPR AND GLD MICE/

      European Journal of Immunology
    98. MEINL E; HOCH RM; DORNMAIR K; MALEFYT RD; BONTROP RE; JONKER M; LASSMANN H; HOHLFELD R; WEKERLE H; THART BA
      ENCEPHALITOGENIC POTENTIAL OF MYELIN BASIC PROTEIN-SPECIFIC T-CELLS ISOLATED FROM NORMAL RHESUS MACAQUES

      The American journal of pathology
    99. LUCCHINETTI CF; BRUCK W; RODRIGUEZ M; LASSMANN H
      DISTINCT PATTERNS OF MULTIPLE-SCLEROSIS PATHOLOGY INDICATES HETEROGENEITY IN PATHOGENESIS

      Brain pathology
    100. BANCHER C; JELLINGER K; LASSMANN H; FISCHER P; LEBLHUBER F
      CORRELATIONS BETWEEN MENTAL STATE AND QUANTITATIVE NEUROPATHOLOGY IN THE VIENNA LONGITUDINAL-STUDY ON DEMENTIA

      European archives of psychiatry and clinical neuroscience


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 10:50:49